Kim DW, Kim SW, Camidge DR, Shu CA, et al. CD73 Inhibitor Oleclumab Plus Osimertinib in Previously Treated Patients With Advanced T790M-Negative EGFRm Non-Small-Cell Lung Cancer: A Brief Report. J Thorac Oncol 2023 Jan 11:S1556-0864(22)01997.
PMID: 36641093